Publications

Bubonic plague: can the size of buboes be accurately and consistently measured with a digital calliper?

Bourner J. et al, (2023), Trials, 24

A multi-country analysis of COVID-19 hospitalizations by vaccination status.

Gonçalves BP. et al, (2023), Med (New York, N.Y.), 4, 797 - 812.e2

Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry.

Griffee MJ. et al, (2023), Research and practice in thrombosis and haemostasis, 7

Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19.

Wainstein M. et al, (2023), Kidney international reports

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376

Neurological manifestations of COVID-19 in adults and children.

Cho S-M. et al, (2023), Brain : a journal of neurology, 146, 1648 - 1661

Liver injury in hospitalized patients with COVID-19: An International observational cohort study.

Tirupakuzhi Vijayaraghavan BK. et al, (2023), PloS one, 18

Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients

Baruch J. et al, (2022), Influenza and Other Respiratory Viruses, 16, 1040 - 1050

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

Reyes LF. et al, (2022), Critical Care, 26

Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP): a pragmatic randomised controlled trial

Beard DJ. et al, (2022), The Lancet, 400, 605 - 615

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

Abbas A. et al, (2022), Scientific Data, 9

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani O. et al, (2022), The Lancet, 399, 665 - 676

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani O. et al, (2022), The Lancet, 399, 143 - 151

The value of open-source clinical science in pandemic response: lessons from ISARIC

Abbas A. et al, (2021), The Lancet Infectious Diseases, 21, 1623 - 1624

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Abdukahil SA. et al, (2021), Infection, 49, 889 - 905

Characteristics and outcomes of an international cohort of 400,000 hospitalised patients with Covid-19

Kartsonaki C., (2021)

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Abani O. et al, (2021), The Lancet, 397, 2049 - 2059

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abani O. et al, (2021), The Lancet, 397, 1637 - 1645

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2021)

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial

Horby PW. et al, (2021)

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Abaleke E. et al, (2021), The Lancet, 397, 605 - 612

Global outbreak research: harmony not hegemony

Akhvlediani T. et al, (2020), The Lancet Infectious Diseases, 20, 770 - 772

Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel

Saxena A. et al, (2019), BMC Medical Ethics, 20

Clinical REsearch During Outbreaks (CREDO) Training for Low- and Middle-Income Countries

Kayem ND. et al, (2019), Emerging Infectious Diseases, 25, 2084 - 2087

CLINICAL CHARACTERISTICS OF PATIENTS ADMITTED TO PNEUMONIC PLAGUE TREATMENT CENTERS DURING THE 2017 MADAGASCAR PNEUMONIC PLAGUE OUTBREAK: A PROSPECTIVE OBSERVATIONAL STUDY

Salam A. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 409 - 409

A training curriculum for conducting clinical research during outbreaks

Horby P. et al, (2017), TROPICAL MEDICINE & INTERNATIONAL HEALTH, 22, 167 - 168

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Baigent C. et al, (2011), The Lancet, 377, 2181 - 2192

Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease

SHARP Collaborative Group None., (2010), American Heart Journal, 160, 785 - 794.e10

Clinical Research in Resource-Limited Settings: Enhancing Research Capacity and Working Together to Make Trials Less Complicated

Lang TA. et al, (2010), PLoS Neglected Tropical Diseases, 4, e619 - e619

Cookies on this website

Publications